✦ LIBER ✦

791 CHEMOTHERAPY WITH GEMCITABINE, PACLITAXEL, AND CISPLATIN IN THE TREATMENT OF PATIENTS WITH INFILTRATIVE TRANSITIONAL CELL CARCINOMA OF THE UROTHELIUM

✍ Scribed by T.H. Ecke; P. Bartel; F. Theissig; S. Koch; J. Ruttloff

Book ID: 119618108
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 315 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60786-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel, Carboplatin, and Gemcitabine

Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Carcinoma of the Urothelium

✍ Hainsworth, J.D.; Meluch, A.A.; Litchy, S.; Schnell, F.M.; Bearden, J.D.; Yost, 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 36 KB

Gemcitabine and paclitaxel combination t

Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium

✍ A.A Meluch; H.S Burris; F.A Greco; J.D Hainsworth 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Re: Final results of sequential doxorubi

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

✍ Christopher J. Logothetis; Arlene Siefker-Radtke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Our experience with 23 consecutive patie

Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium

✍ BERND HOSCHKE; MATTHIAS MAY; MATTHIAS SEEHAFER; CHRISTIAN HELKE 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Enterocolitis related to chemotherapy wi

Enterocolitis related to chemotherapy with gemcitabine and cisplatin in patient with transitional cell carcinoma of ureter

✍ Y.J. YANG; J.S. LIM; H.J. LEE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Chemotherapy with an every-2-week regime

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy

✍ Cora N. Sternberg; Fabio Calabrò; Giorgio Pizzocaro; Luca Marini; Sylvia Schnetz 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views